Spotlight on dinutuximab in the treatment of high-risk neuroblastoma: development and place in therapy.

Saved in:
Bibliographic Details
Title: Spotlight on dinutuximab in the treatment of high-risk neuroblastoma: development and place in therapy.
Authors: Keyel ME; Cancer Center, Patrick.Reynolds@ttuhsc.edu.; Department of Pediatrics, Patrick.Reynolds@ttuhsc.edu., Reynolds CP; Cancer Center, Patrick.Reynolds@ttuhsc.edu.; Department of Pediatrics, Patrick.Reynolds@ttuhsc.edu.; Department of Internal Medicine, Patrick.Reynolds@ttuhsc.edu.; Department of Cell Biology & Biochemistry, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, USA, Patrick.Reynolds@ttuhsc.edu.
Source: Biologics : targets & therapy [Biologics] 2018 Dec 21; Vol. 13, pp. 1-12. Date of Electronic Publication: 2018 Dec 21 (Print Publication: 2019).
Publication Type: Journal Article; Review
Journal Info: Publisher: Dove Medical Press (NZ) Country of Publication: New Zealand NLM ID: 101321511 Publication Model: eCollection Cited Medium: Print ISSN: 1177-5475 (Print) Linking ISSN: 11775475 NLM ISO Abbreviation: Biologics Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 30613134
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Spotlight on dinutuximab in the treatment of high-risk neuroblastoma: development and place in therapy.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Keyel+ME%22">Keyel ME</searchLink>; Cancer Center, Patrick.Reynolds@ttuhsc.edu.; Department of Pediatrics, Patrick.Reynolds@ttuhsc.edu.<br /><searchLink fieldCode="AU" term="%22Reynolds+CP%22">Reynolds CP</searchLink>; Cancer Center, Patrick.Reynolds@ttuhsc.edu.; Department of Pediatrics, Patrick.Reynolds@ttuhsc.edu.; Department of Internal Medicine, Patrick.Reynolds@ttuhsc.edu.; Department of Cell Biology & Biochemistry, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, USA, Patrick.Reynolds@ttuhsc.edu.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101321511%22">Biologics : targets & therapy</searchLink> [Biologics] 2018 Dec 21; Vol. 13, pp. 1-12. <i>Date of Electronic Publication: </i>2018 Dec 21 (<i>Print Publication: </i>2019).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Dove+Medical+Press+%28NZ%29%22">Dove Medical Press (NZ) </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>101321511 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1177-5475 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2211775475%22">11775475 </searchLink><i>NLM ISO Abbreviation: </i>Biologics <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=30613134
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.2147/BTT.S114530
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1
    Titles:
      – TitleFull: Spotlight on dinutuximab in the treatment of high-risk neuroblastoma: development and place in therapy.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Keyel ME
      – PersonEntity:
          Name:
            NameFull: Reynolds CP
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 21
              M: 12
              Text: 2018 Dec 21
              Type: published
              Y: 2018
          Identifiers:
            – Type: issn-print
              Value: 1177-5475
          Numbering:
            – Type: volume
              Value: 13
          Titles:
            – TitleFull: Biologics : targets & therapy
              Type: main
ResultId 1